Tris Pharma, Inc. v. Actavis Laboratories FL, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP
Almost four years ago, in a relatively rare occurrence based on there being an insufficient factual record to permit proper appellate review, the Federal Circuit vacated a District...
Source: jdsupra.com